Stay updated on Magrolimab Combo in New AML/HR-MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.

Latest updates to the Magrolimab Combo in New AML/HR-MDS Clinical Trial page
- Check2 days agoChange DetectedRecord history now shows a new revision entry (v3.3.2) and removal of the previous revision (v3.3.1), reflecting a versioning update to the record rather than substantive changes to the study.SummaryDifference0.1%

- Check9 days agoChange DetectedThe record history shows a new revision v3.3.1 replacing v3.2.0. It does not reflect substantive changes to the study data or status.SummaryDifference0.1%

- Check17 days agoChange DetectedThe funding-related notice about information potentially not being up to date was removed from the page. This change eliminates a transparency warning regarding data currency on the trial record.SummaryDifference0.8%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRecord History now shows updates to Study Status on 2023-08-17 and 2023-11-28, and a Recruitment Status update on 2024-02-09. These entries reflect progression changes in the trial and its recruitment status.SummaryDifference0.1%

- Check59 days agoChange DetectedMajor update: alerts about government funding status and a new v3.2.0 release. Prior version v3.1.0 was removed.SummaryDifference13%

- Check67 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Magrolimab Combo in New AML/HR-MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.